County
Pierce County Emergency Medical Services
Pierce County Emergency Medical Services (Tacoma, WA) carries 62 drugs across 320 dose entries in its current published protocol, effective 2025-02-01.
Drugs and doses62
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 56 |
| Mild to moderate pain | adult | 500–1000 mg | PO | not captured | standing | page 48 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 48 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 104 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 104 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2.5 mg | not captured | not captured | standing | page 51 |
| Allergic reaction | peds | 2.5 mg | not captured | not captured | standing | page 51 |
| Asthma / bronchospasm | adult | 2.5 mg | not captured | not captured | standing | page 51 |
| Asthma / bronchospasm | adult | 2.5 mg | not captured | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 2.5 mg | not captured | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 2.5 mg | not captured | not captured | standing | page 51 |
| COPD | adult | 2.5 mg | not captured | not captured | standing | page 51 |
| COPD | peds | 2.5 mg | not captured | not captured | standing | page 51 |
| Crush injury | adult | 2.5 mg | not captured | not captured | standing | page 42 |
| Crush injury | peds | 2.5 mg | not captured | not captured | standing | page 42 |
| Hyperkalemia | adult | 2.5 mg | not captured | not captured | standing | page 58 |
| Hyperkalemia | peds | 2.5 mg | not captured | not captured | standing | page 58 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 107 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 107 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 107 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 45 |
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 45 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 109 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 109 |
| Nerve agent exposure | adult | 2 mg | IV | not captured | standing | page 110 |
| Nerve agent exposure | peds | 0.05 mg/kg | IV | not captured | standing | page 110 |
| Organophosphate poisoning | adult | 2 mg | IV | not captured | standing | page 110 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | page 110 |
| Other | adult | 0.5 mg | IV/IO/IM | not captured | standing | page 71 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV | not captured | standing | page 111 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV | not captured | standing | page 111 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | page 111 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV | not captured | standing | page 111 |
| Crush injury | adult | 500–1000 mg | IV | not captured | standing | page 111 |
| Crush injury | peds | 20 mg/kg | IV | not captured | standing | page 111 |
| Hyperkalemia | adult | 500–1000 mg | IV | not captured | standing | page 111 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | page 111 |
| Other | adult | 1000 mg | IV | not captured | standing | page 111 |
| Other | adult | 500–1000 mg | IV | not captured | standing | page 111 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 111 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 111 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 15–30 mL | IV | not captured | standing | page 113 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV | not captured | standing | page 113 |
| Crush injury | adult | 15–30 mL | IV | not captured | standing | page 113 |
| Crush injury | peds | 60 mg/kg | IV | not captured | standing | page 113 |
| Hyperkalemia | adult | 15–30 mL | IV | not captured | standing | page 113 |
| Hyperkalemia | peds | 60 mg/kg | IV | not captured | standing | page 113 |
| Other | adult | 15–30 mL | IV | not captured | standing | page 113 |
| Other | peds | 60 mg/kg | IV | not captured | standing | page 113 |
Cetirizine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | PO | not captured | standing | page 114 |
| Allergic reaction | adult | 10 mg | PO | not captured | standing | page 114 |
| Allergic reaction | peds | 5 mg | PO | not captured | standing | page 114 |
| Allergic reaction | peds | 5 mg | PO | not captured | standing | page 114 |
| Anaphylaxis | adult | 5–10 mg | PO | not captured | standing | page 65 |
| Anaphylaxis | peds | 5 mg | PO | not captured | standing | page 65 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.6 mg/kg | IV/PO | not captured | standing | page 117 |
| Allergic reaction | adult | 0.6 mg/kg | IV/PO | not captured | standing | page 117 |
| Allergic reaction | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 117 |
| Allergic reaction | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 117 |
| Anaphylaxis | adult | 0.6 mg/kg | IV/PO | not captured | standing | page 117 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 117 |
| Asthma / bronchospasm | adult | 0.6 mg/kg | IV/PO | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/PO | not captured | standing | page 51 |
| COPD | adult | 0.6 mg/kg | IV/PO | not captured | standing | page 51 |
| Croup | peds | 0.6 mg/kg | PO | not captured | standing | page 52 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mL | IV/IO | not captured | standing | page 118 |
| Crush injury | peds | 1 mL/kg | IV/IO | not captured | standing | page 118 |
| Hypoglycemia | adult | 50 mL | IV/IO | not captured | standing | page 55 |
| Other | adult | 50 mL | IV/IO | not captured | standing | page 118 |
| Other | peds | 1 mL/kg | IV/IO | not captured | standing | page 118 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 119 |
| Alcohol withdrawal | adult | 5–10 mg | IV/IM | not captured | standing | page 68 |
| Hyperactive delirium | adult | 5–10 mg | IV/IM | not captured | standing | page 70 |
| Other | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 119 |
| Procedural sedation | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 119 |
| RSI induction | adult | 2–10 mg | IV/IO/IM | not captured | standing | page 119 |
| Seizure | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 37 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 37 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 15–20 mg | IV | not captured | standing | page 121 |
| Atrial fibrillation with RVR | adult | 15–20 mg | IV | not captured | standing | page 121 |
| SVT | adult | 15–20 mg | IV | not captured | standing | page 121 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IM | not captured | standing | page 65 |
| Allergic reaction | adult | 25–50 mg | IV | not captured | standing | page 65 |
| Allergic reaction | adult | 50 mg | PO | not captured | standing | page 65 |
| Allergic reaction | peds | 1 mg/kg | IM | not captured | standing | page 65 |
| Allergic reaction | peds | 1 mg/kg | IV | not captured | standing | page 65 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | page 65 |
| Anaphylaxis | adult | 25–50 mg | IM | not captured | standing | page 66 |
| Anaphylaxis | adult | 25–50 mg | IV/IO | not captured | standing | page 66 |
| Anaphylaxis | adult | 50 mg | PO | not captured | standing | page 66 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | page 66 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO | not captured | standing | page 66 |
| Anaphylaxis | peds | 1 mg/kg | PO | not captured | standing | page 66 |
| Dystonic reaction | adult | 25–50 mg | IM | not captured | standing | page 57 |
| Dystonic reaction | adult | 25–50 mg | IV/IO | not captured | standing | page 57 |
| Dystonic reaction | peds | 1 mg/kg | IM | not captured | standing | page 57 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO | not captured | standing | page 57 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 59 |
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 59 |
| Cardiogenic shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 59 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 59 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 59 |
| Sepsis | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 59 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 1.25–2.5 mg | IM | not captured | standing | page 125 |
| Hyperactive delirium | adult | 1.25–2.5 mg | IV | not captured | standing | page 125 |
| Nausea / vomiting | adult | 1.25–2.5 mg | IM | not captured | standing | page 125 |
| Nausea / vomiting | adult | 1.25–2.5 mg | IV | not captured | standing | page 125 |
| Other | adult | 1.25–2.5 mg | IM | not captured | standing | page 125 |
| Other | adult | 1.25–2.5 mg | IV | not captured | standing | page 125 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3–0.5 mg | IM | not captured | standing | page 65 |
| Allergic reaction | peds | 0.01 mg/kg | IM | not captured | standing | page 65 |
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 66 |
| Anaphylaxis | adult | 0.5 mg | IV/IO | not captured | standing | page 66 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 66 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 51 |
| Bradycardia | adult | 0.5–2 mL | IV/IO | not captured | standing | page 59 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 59 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 127 |
| Cardiac arrest | adult | 2–2.5 mg | ET | not captured | standing | page 127 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 127 |
| Croup | peds | 2–3 mL | not captured | not captured | standing | page 52 |
| Hypotension / shock | adult | 0.5–2 mL | IV/IO | not captured | standing | page 59 |
| Other | adult | 0.3 mg | IM | not captured | standing | page 52 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 52 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Procedural sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 129 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 129 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 129 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20 mg | IV | not captured | standing | page 130 |
| Allergic reaction | peds | 0.25 mg/kg | IV | not captured | standing | page 130 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | page 48 |
| Severe pain | peds | 1–2 mcg/kg | IV/IO/IM/IN | not captured | standing | page 48 |
| RSI induction | adult | 1 mcg/kg | IV/IO | not captured | standing | page 87 |
| RSI induction | peds | 1 mcg/kg | IV/IO | not captured | standing | page 87 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–3 mg | IV | not captured | standing | page 67 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–10 mg | IV | not captured | standing | page 57 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 56 |
| Hypoglycemia | adult | 3 mg | IN | not captured | standing | page 56 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 56 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–5 mg | IM | not captured | standing | page 134 |
| Other | peds | 0.025 mg/kg | IM | not captured | standing | page 134 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.01 mg/kg | IM | not captured | standing | page 135 |
| Severe pain | adult | 0.01 mg/kg | IV/IO | not captured | standing | page 135 |
| Severe pain | peds | 0.01 mg/kg | IM | not captured | standing | page 135 |
| Severe pain | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 135 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 115 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | page 115 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400–800 mg | PO | not captured | standing | page 48 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 48 |
| Mild to moderate pain | adult | 400–800 mg | PO | not captured | standing | page 48 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 48 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | not captured | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 0.25 mg | not captured | not captured | standing | page 51 |
Isopropyl Alcohol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | Deep inhalations of the alcohol medical pad 1–2 cm away from the nose | NEB | not captured | standing | page 58 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg/kg | IV | not captured | standing | page 69 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 69 |
| Severe pain | adult | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 48 |
| Severe pain | peds | 0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 48 |
| Post-intubation sedation | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 87 |
| Post-intubation sedation | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 87 |
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 89 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 87 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 87 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 89 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15–30 mg | IV | not captured | standing | page 141 |
| Severe pain | adult | 30–60 mg | IM | not captured | standing | page 141 |
| Severe pain | peds | 0.5 mg/kg | IM | not captured | standing | page 141 |
| Severe pain | peds | 0.5 mg/kg | IV | not captured | standing | page 141 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 60 mg/kg | IV | not captured | standing | page 37 |
| Seizure | peds | 60 mg/kg | IV | not captured | standing | page 37 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | Moderate amount | TOP | not captured | standing | page 188 |
| Other | peds | Moderate amount | TOP | not captured | standing | page 188 |
| Mild to moderate pain | adult | 20–50 mg | IO | not captured | standing | page 29 |
| RSI induction | adult | Moderate amount | TOP | not captured | standing | page 188 |
| RSI induction | peds | Moderate amount | TOP | not captured | standing | page 188 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV/IO | not captured | standing | page 144 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 144 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 144 |
| VF / pulseless VT | adult | 2–3 mg/kg | ET | not captured | standing | page 144 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 144 |
| VF / pulseless VT | peds | 2–3 mg/kg | ET | not captured | standing | page 144 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.5–2 mg | IV/IO/IM/PR | not captured | standing | page 146 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO/IM/PR | not captured | standing | page 146 |
| Status epilepticus | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 146 |
| Status epilepticus | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 146 |
Low Titer O Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 36 |
| Trauma / hemorrhage | peds | 20 mL/kg | IV/IO | not captured | standing | page 36 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | page 51 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 75 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 75 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 149 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 149 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 149 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 149 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV | not captured | standing | page 65 |
| Allergic reaction | adult | 125 mg | IV | not captured | standing | page 152 |
| Allergic reaction | peds | 2 mg/kg | IV | not captured | standing | page 65 |
| Allergic reaction | peds | 2 mg/kg | IV | not captured | standing | page 152 |
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 66 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 66 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 51 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | page 51 |
| COPD | adult | 125 mg | IV | not captured | standing | page 51 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.2 mg/kg | IN | not captured | standing | page 153 |
| Agitation | peds | 0.2 mg/kg | IN | not captured | standing | page 153 |
| Hyperactive delirium | adult | 10 mg | IV/IM/IN | not captured | standing | page 70 |
| Post-intubation sedation | adult | 2 mg | IV/IO | not captured | standing | page 154 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 154 |
| Procedural sedation | adult | 2 mg | IV/IO | not captured | standing | page 153 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 153 |
| Seizure | adult | 0.1 mg/kg | IV | not captured | standing | page 37 |
| Seizure | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 37 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | page 37 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 37 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV | not captured | standing | page 48 |
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 155 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 155 |
| Severe pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 48 |
| Severe pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 48 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 53 |
| Neonatal resuscitation | peds | 0.1 mg/kg | IV/IO/IM/IN/SQ/ET | not captured | standing | page 57 |
| Opioid overdose | adult | 0.4–4 mg | IV/IO/IM/IN/ET | not captured | standing | page 53 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 53 |
| Other | adult | 0.4–4 mg | IV/IO/IM/IN/ET | not captured | standing | page 53 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 53 |
| Respiratory distress | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | page 53 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1 auto-injector | IM | not captured | standing | page 65 |
| Organophosphate poisoning | adult | 1 auto-injector | IM | not captured | standing | page 65 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 45 |
| CHF / pulmonary edema | adult | 0.4–0.8 mg | SL | not captured | standing | page 50 |
Nitrous Oxide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 50% oxygen/50% nitrous oxide mix | NEB | not captured | standing | page 161 |
| Severe pain | adult | 50% oxygen/50% nitrous oxide mix | NEB | not captured | standing | page 161 |
| Trauma / hemorrhage | adult | 50% oxygen/50% nitrous oxide mix | NEB | not captured | standing | page 161 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 0.1 mcg/kg | IV | not captured | standing | page 162 |
| Cardiogenic shock | peds | 0.1 mcg/kg | IV | not captured | standing | page 162 |
| Hypotension / shock | adult | 0.1 mcg/kg | IV | not captured | standing | page 51 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV | not captured | standing | page 51 |
| Sepsis | adult | 0.1 mcg/kg | IV | not captured | standing | page 162 |
| Sepsis | peds | 0.1 mcg/kg | IV | not captured | standing | page 162 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IM | not captured | standing | page 164 |
| Agitation | peds | 2.5–5 mg | IM | not captured | standing | page 164 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 58 |
| Nausea / vomiting | adult | 4 mg | IM | not captured | standing | page 165 |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | page 165 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV | not captured | standing | page 58 |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | page 165 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 tube | PO | not captured | standing | page 55 |
| Hypoglycemia | peds | 1 tube | PO | not captured | standing | page 55 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–3 spray | IN | not captured | standing | page 38 |
| Other | peds | 2–3 spray | IN | not captured | standing | page 38 |
| RSI induction | adult | 2–3 spray | IN | not captured | standing | page 28 |
| RSI induction | peds | 2–3 spray | IN | not captured | standing | page 28 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 75 |
| Obstetric hemorrhage | adult | 20 unit | IV | not captured | standing | page 75 |
Pancuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 169 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 169 |
Phenobarbital
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 65 mg | IV | not captured | standing | page 170 |
| Seizure | adult | 260 mg | IV | not captured | standing | page 170 |
| Seizure | peds | 20 mg/kg | IV | not captured | standing | page 170 |
Plasma
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 unit | IV/IO | not captured | standing | page 61 |
| Trauma / hemorrhage | peds | 20 mL/kg | IV/IO | not captured | standing | page 61 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | page 65 |
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | page 65 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 20 mg | IV/IO | not captured | standing | page 176 |
| Atrial fibrillation with RVR | peds | 15 mg/kg | IV/IO | not captured | standing | page 176 |
| Wide-complex tachycardia | adult | 20 mg | IV/IO | not captured | standing | page 176 |
| Wide-complex tachycardia | adult | 20 mg | IV/IO | not captured | standing | page 176 |
| Wide-complex tachycardia | peds | 15 mg/kg | IV/IO | not captured | standing | page 176 |
| Wide-complex tachycardia | peds | 15 mg/kg | IV/IO | not captured | standing | page 176 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 2.5–5 mg | IV | not captured | standing | page 177 |
| Nausea / vomiting | adult | 2.5–5 mg | IV | not captured | standing | page 177 |
| Nausea / vomiting | adult | 5–10 mg | IM | not captured | standing | page 177 |
| Nausea / vomiting | adult | 5–10 mg | IM | not captured | standing | page 177 |
| Nausea / vomiting | peds | 0.1 mg/kg | IM | not captured | standing | page 177 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 177 |
| Nausea / vomiting | peds | 0.1 mg/kg | IM | not captured | standing | page 177 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 177 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IV/IM/PR | not captured | standing | page 178 |
| Nausea / vomiting | adult | 12.5–25 mg | IV/IM/PR | not captured | standing | page 178 |
| Nausea / vomiting | peds | 0.25–0.5 mg/kg | IV/IM/PR | not captured | standing | page 178 |
| Nausea / vomiting | peds | 0.25–0.5 mg/kg | IV/IM/PR | not captured | standing | page 178 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 87 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 87 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 100 mEq | IV | not captured | standing | page 43 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 180 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 180 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 57 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 87 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 87 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1–2 g | IV/IO | not captured | standing | page 183 |
| Allergic reaction | peds | 15 mg/kg | IV/IO | not captured | standing | page 183 |
| Trauma / hemorrhage | adult | 1–2 g | IV/IO | not captured | standing | page 36 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 36 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.03 unit | IV/IO | not captured | standing | page 185 |
| Sepsis | adult | 0.03 unit | IV/IO | not captured | standing | page 185 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 186 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 186 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 2.5–5 mg | IV/IO | not captured | standing | page 187 |
| SVT | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 187 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 10–20 mg | IM | not captured | standing | page 189 |
| Hyperactive delirium | peds | 10 mg | IM | not captured | standing | page 189 |
| Other | adult | 10–20 mg | IM | not captured | standing | page 189 |
| Other | peds | 10 mg | IM | not captured | standing | page 189 |